🎯 check Omaveloxolone (RTA-408) product page
Omaveloxolone (RTA-408) is a potent Keap1 inhibitor and Nrf2 activator. It affects Nrf2/ARE and NF-κB signaling pathways by binding to Keap1 to prevent Nrf2 ubiquitination, effectively inhibiting oxidative stress, inflammation, and viral replication while promoting mitochondrial function and neuroprotection.